切换至 "中华医学电子期刊资源库"

中华腔镜泌尿外科杂志(电子版) ›› 2019, Vol. 13 ›› Issue (04) : 280 -284. doi: 10.3877/cma.j.issn.1674-3253.2019.04.016

所属专题: 经典病例 经典病例 文献

病例研究

腹膜后巨大脂肪肉瘤一例报告并文献复习
郑建坤1, 黄展森2, 王德娟3, 黄文涛4, 李科4, 胡成4, 邱剑光3,()   
  1. 1. 516211 广东,惠州市第六人民医院泌尿外科
    2. 510630 广州,中山大学附属第三医院不育与性医学科
    3. 510655 广州,中山大学附属第六医院泌尿外科
    4. 510630 广州,中山大学附属第三医院泌尿外科
  • 收稿日期:2018-03-14 出版日期:2019-08-01
  • 通信作者: 邱剑光
  • 基金资助:
    广东省自然基金(2017A030313898); 广东省科技计划(2017A020215028); 广州市科技计划(201707010113); 广州市珠江科技新星人才专项(201710010039); 中山大学青年教师培育项目(17ykpy48)

Huge retroperitoneal liposarcoma: one case report and literature review

Jiankun Zheng1, Zhansen Huang2, Dejuan Wang3, Wentao Huang4, Ke Li4, Cheng Hu4, Jianguang Qiu3,()   

  1. 1. Department of Urology, the Sixth People′s Hospital of Huizhou, Guangdong 516211, China
    2. Department of Infertility and Sexual Medicine, the Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510630, China
    3. Department of Urology, the Sixth Affiliated Hospital of Sun Yat-Sen University , Guangzhou 510655, China
    4. Department of Urology, the Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510630, China
  • Received:2018-03-14 Published:2019-08-01
  • Corresponding author: Jianguang Qiu
  • About author:
    Corresponding author: Qiu Jianguang, Email:
引用本文:

郑建坤, 黄展森, 王德娟, 黄文涛, 李科, 胡成, 邱剑光. 腹膜后巨大脂肪肉瘤一例报告并文献复习[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2019, 13(04): 280-284.

Jiankun Zheng, Zhansen Huang, Dejuan Wang, Wentao Huang, Ke Li, Cheng Hu, Jianguang Qiu. Huge retroperitoneal liposarcoma: one case report and literature review[J/OL]. Chinese Journal of Endourology(Electronic Edition), 2019, 13(04): 280-284.

目的

探讨腹膜后巨大脂肪肉瘤术后腹腔复发患者多学科诊疗模式(MDT)。

方法

回顾性分析腹膜后巨大脂肪肉瘤术后腹腔复发患者1例,男,45岁,复发肿瘤大小约10 cm×9 cm的临床病例资料及其两次诊治过程及MDT讨论要点分析,复习总结国内外相关文献。

结果

患者行开放腹腔多发肿物切除+胆囊切除+大网膜切除术成功切除肿瘤,术后病理为去分化型脂肪内瘤。经治疗后恢复良好出院。一个半月后复发,继续靶向药物(阿帕替尼500 mg qd)治疗。

结论

腹膜后脂肪肉瘤早期诊断困难,手术难度大,MDT及结合影像学检查及临床病理学特征可作出正确诊断,充分评估早期手术治疗可获得一定疗效,但去分化型脂肪内瘤总体预后不良。

Objective

To explore the multi-disciplinary team (MDT) for patients with peritoneal tumor recurrence after surgical resection of retroperitoneal giant liposarcoma.

Methods

Clinical data of a 45-year-old male patient with peritoneal tumor recurrence approximately 10 cm×9 cm in size after surgical resection of retroperitoneal giant liposarcoma were retrospectively analyzed. The procedures of two cycles of diagnoses and treatments and MDT highlights were reviewed. Relevant literatures at home and abroad were summarized.

Results

The patient underwent open resection of multiple abdominal tumors + cholecystectomy + omentectomy to successfully resect the tumors. Postoperative pathological examination confirmed the diagnosis of dedifferentiated lipoblastoma. The patient was recovered and discharged after treatment. At postoperative 45 d, the patient recurred and continued to be treated with targeted drugs (Apatinib at 500 mg qd).

Conclusion

It is difficult to deliver early diagnosis of retroperitoneal liposarcoma and perform the operation. MDT combined with imaging examination and clinicopathological features can make an accurate diagnosis. Comprehensive evaluation of early surgery can achieve certain clinical efficacy, whereas the overall prognosis of patients with dedifferentiated liposarcoma is poor.

图1 腹膜后巨大脂肪肉瘤患者影像图片及术中图片、标本
图2 脂肪肉瘤(去分化脂肪肉瘤,HE染色,×40)
[1]
Pasquali S, Gronchi A. Neoadjuvant chemotherapy in soft tissue sarcomas: latest evidence and clinical implications[J]. Ther Adv Med Oncol, 2017, 9 (6): 415-429.
[2]
Anaya DA1, Lahat G, Liu J, et al. Pollock Multifocality in retroperitoneal sarcoma: a prognostic factor critical to surgical decision-making[J]. Ann Surg, 2009, 249 (1): 137-142.
[3]
Bonvalot S, Rivoire M, Castaing M, et al. Laplanche Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control[J]. J Clin Oncol, 2009, 27(1): 31-37.
[4]
Ballo MT, Zagars GK, Pollock RE, et al. Retroperitoneal soft tissue sarcoma: an analysis of radiation and surgical treatment[J]. Int J Radiat Oncol Biol Phys, 2007, 67(1): 158-163.
[5]
Choi AH, Barnholtz-Sloan JS, Kim JA. Kim Effect of radiation therapy on survival in surgically resected retroperitoneal sarcoma: a propensity score-adjusted SEER analysis[J]. Ann Oncol, 2012, 23(9): 2449-2457.
[6]
Puzio-Kuter AM, Laddha SV, Castillo-Martin M, et al. Involvement of tumor suppressors PTEN and p 53 in the formation of multiple subtypes of liposarcoma[J]. Cell Death Differ, 2015, 22(11): 1785-1791.
[7]
Samuels BL, Chawla SP, Somaiah N, et al. Stepanski Results of a prospective phase 2 study of pazopanib in patients with advanced intermediate-grade or high-grade liposarcoma[J]. Cancer, 2017, 123(23): 4640-4647.
[8]
Erzen D, Sencar M, Novak J. Retroperitoneal sarcoma: 25 years of experience with aggressive surgical treatment at the Institute of Oncology Ljubljana[J]. J Surg Oncol, 2005, 91(1): 1-9.
[9]
Henricks WH, Chu YC, Goldblum JR, et al. Dedifferentiated liposarcoma: a clinicopathological analysis of 155 cases with a proposal for an expanded definition of dedifferentiation[J]. Am J Surg Pathol, 1997, 21(3): 271-281.
[10]
Gronchi A, Ferrari S, Quagliuolo V, et al. Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial[J]. Lancet Oncol, 2017, 18 (6): 812-822.
[11]
Gunderson LL, Shipley WU, Suit HD, et al. Intraoperative irradiation: a pilot study combining external beam photons with "boost" dose intraoperative electrons[J]. Cancer 1982, 49 (11): 2259-2266.
[12]
Mariani O, Brennetot C, Coindre JM, et al. JUN oncogene amplification and overexpression block adipocytic differentiation in highly aggressive sarcomas[J]. Cancer Cell, 2007, 11 (4): 361-374.
[13]
Tuan J, Vitolo V, Vischioni B, et al. Radiation therapy for retroperitoneal sarcoma[J]. Radiol Med, 2014, 119 (10): 790-802.
[14]
Ecker BL, Peters MG1, McMillan MT, et al. Preoperative radiotherapy in the management of retroperitoneal liposarcoma[J]. Br J Surg, 2016, 103 (13): 1839-1846.
[15]
Marinello P, Montresor E, Iacono C, et al. Long-term results of aggressive surgical treatment of primary and recurrent retroperitoneal liposarcomas[J]. Chir Ital, 2001, 53 (2): 149-157.
[16]
Demetri GD, Chawla SP, von Mehren M, et al. Efficacy and safety of trabectedin in patients with advanced or metastatic liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide: results of a randomized phase II study of two different schedules[J]. J Clin Oncol, 2009, 27 (25): 4188-4196.
[17]
Nathan H, Raut CP, Thornton K, et al. Predictors of survival after resection of retroperitoneal sarcoma: a population-based analysis and critical appraisal of the AJCC staging system[J]. Ann Surg, 2009, 250(6): 970-976.
[18]
Sogaard AS, Laurberg JM, Sorensen M, et al. Intraabdominal and retroperitoneal soft-tissue sarcomas--outcome of surgical treatment in primary and recurrent tumors[J]. World J Surg Oncol, 2010, 8(1): 81.
[19]
Strauss DC, Hayes AJ, Thway K, et al. Surgical management of primary retroperitoneal sarcoma[J]. Br J Surg, 2010, 97(5): 698-706.
[20]
Singer S, Alektiar K. Alektiar treatment recommendations for retroperitoneal liposarcoma[J]. Int J Radiat Oncol Biol Phys, 2017, 98(2): 271.
[21]
Gilbeau L, Kantor G, Stoeckle E, et al. Surgical resection and radiotherapy for primary retroperitoneal soft tissue sarcoma[J]. Radiother Oncol, 2002, 65 (3): 137-143.
[1] 孙佳丽, 金琳, 沈崔琴, 陈晴晴, 林艳萍, 李朝军, 徐栋. 机器人辅助超声引导下经皮穿刺的体外实验研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(09): 884-889.
[2] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[3] 刘世君, 马杰, 师鲁静. 胃癌完整系膜切除术+标准D2根治术治疗进展期胃癌的近中期随访研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 27-30.
[4] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[5] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[6] 韩戟, 杨力, 陈玉. 腹部形态CT参数与完全腹腔镜全胃切除术术中失血量的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 88-91.
[7] 王露, 周丽君. 全腹腔镜下远端胃大部切除不同吻合方式对胃癌患者胃功能恢复、并发症发生率的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 92-95.
[8] 孙一娇, 包润发, 董平, 束翌俊. PBL结合手术视频剪辑教学在普通外科专科医师规范化培训中的应用与思考[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 96-99.
[9] 陈浩, 王萌. 胃印戒细胞癌的临床病理特征及治疗选择的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 108-111.
[10] 孙莲, 马红萍, 吴文英. 局部进展期甲状腺癌患者外科处理[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 112-114.
[11] 刘柏隆. 女性压力性尿失禁阶梯治疗之手术治疗方案选择[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 126-126.
[12] 刘柏隆, 周祥福. 女性尿失禁吊带手术并发症处理的经验分享[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 127-127.
[13] 周迪, 全志伟. 规范化胆囊良性疾病诊治流程减少胆囊癌误诊误治[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 749-753.
[14] 张耕毓, 唐冲, 张昆, 张辉, 张清华, 刘家帮. 股骨头坏死髓芯减压术的文献计量学分析及单中心病例报道[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 771-780.
[15] 胡云鹤, 周玉焯, 付瑞瑛, 于凡, 李爱东. CHS-DRG付费制度下GB1分组住院费用影响因素分析与管理策略探讨[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 568-574.
阅读次数
全文


摘要